CLDA Insider Trading Activity and SEC Form 4 Filings
CLDA insider trading summary
No open-market insider purchases or sales of Clinical Data Inc (CLDA) have been reported on SEC Form 4 in the past 12 months.
Latest CLDA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 12, 2011 | Dogwood Holding Corp. | 10% Owner | Buy | $836.0M (27,868,256 @ $30.00) |
| Apr 12, 2011 | Forest Laboratories Inc | 10% Owner | Buy | $836.0M (27,868,256 @ $30.00) |
| Apr 12, 2011 | FLI International, LLC | 10% Owner | Buy | $836.0M (27,868,256 @ $30.00) |
| Apr 12, 2011 | Magnolia Acquisition Corp. | 10% Owner | Buy | $836.0M (27,868,256 @ $30.00) |
| Apr 12, 2011 | FL Holding C.V. | 10% Owner | Buy | $836.0M (27,868,256 @ $30.00) |
| Nov 12, 2008 | Drew J Fromkin | CEO, President | Buy | $19K (2,000 @ $9.56) |
| Jun 20, 2008 | Randal J Kirk | Director | Buy | $99K (5,985 @ $16.49) |
| Dec 14, 2007 | Charles Evan Ballantyne | SVP, CFO | Buy | $13K (600 @ $21.63) |
| Dec 14, 2007 | Charles Evan Ballantyne | SVP, CFO | Buy | $2K (100 @ $21.77) |
| Dec 14, 2007 | Charles Evan Ballantyne | SVP, CFO | Buy | $4K (200 @ $22.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.